NewBridge Pharmaceuticals -2018 winner of the Most Innovative Pharmaceutics Commercialisation Partner MENA award

“The www.CFI.co judging panel applauds the company’s mission to address unmet medical needs in the MENA region through strategic joint-ventures and partnerships, naming NewBridge Pharmaceuticals the 2018 winner of the…

NewBridge Pharmaceuticals at WCO-IOF-ESCEO Paris 2019

Joe Henein, the President & CEO of NewBridge Pharmaceuticals, Sherif Hamdy Franchise Head Metabolic Care and Lina Sabbagh Commercial Lead CNS Lebanon attended the World Congress on Osteoporosis, Osteoarthritis and…

NewBridge Pharmaceuticals at EASL 2019

NewBridge President and CEO Joe Henein, Business Director Group Franchise Hisham EL Sayed and Brand Manager Rare Diseases Jennifer Bteich, attended The International Liver Congress “EASL 2019”, that was held…

Sunovion Pharmaceuticals Europe Ltd. and NewBridge Pharmaceuticals Announce Agreement for Distribution of Latuda® (lurasidone) in the Gulf Cooperation Council Region

Sunovion Pharmaceuticals Europe Ltd. (Sunovion) and NewBridge Pharmaceuticals (NewBridge) have signed a distribution agreement to make Latuda® (lurasidone), an atypical antipsychotic, available in the six countries of the Gulf Cooperation…

Aramex inks deal with NewBridge Pharmaceuticals

Published: 18:40 August 23, 2016 (Gulf News) Dubai: Aramex on Tuesday announced its partnership with NewBridge Pharmaceuticals. As part of this collaboration, Aramex said it is now providing a range…

MoH signs MoU with NewBridge to provide free treatment for patients with rheumatoid disease

DUBAI, 15th June, 2016 (WAM) – The Ministry of Health and Prevention has signed a Memorandum of Understanding (MoU) with NewBridge Pharmaceuticals and Axios Gulf Companies, to launch an initiativefor the treatment of patients…